ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,101 | -47.7% | 15,497 | +0.1% | 0.00% | -66.7% |
| Q2 2023 | $331,186 | -40.5% | 15,476 | +12.5% | 0.00% | -40.0% |
| Q1 2023 | $556,414 | -15.0% | 13,759 | -2.3% | 0.01% | -16.7% |
| Q4 2022 | $654,955 | +12.0% | 14,079 | +24.8% | 0.01% | 0.0% |
| Q3 2022 | $585,000 | +0.7% | 11,285 | -8.2% | 0.01% | 0.0% |
| Q2 2022 | $581,000 | -61.3% | 12,287 | -41.8% | 0.01% | -62.5% |
| Q1 2022 | $1,502,000 | -14.6% | 21,103 | -10.3% | 0.02% | -20.0% |
| Q4 2021 | $1,759,000 | +25.0% | 23,521 | -5.0% | 0.02% | +42.9% |
| Q3 2021 | $1,407,000 | +20.2% | 24,771 | -6.9% | 0.01% | +40.0% |
| Q2 2021 | $1,171,000 | -34.6% | 26,597 | -26.8% | 0.01% | -41.2% |
| Q1 2021 | $1,791,000 | +17.2% | 36,324 | +0.1% | 0.02% | 0.0% |
| Q4 2020 | $1,528,000 | +30.4% | 36,292 | +41.8% | 0.02% | 0.0% |
| Q3 2020 | $1,172,000 | -14.5% | 25,595 | -6.2% | 0.02% | -5.6% |
| Q2 2020 | $1,370,000 | -25.7% | 27,285 | -23.9% | 0.02% | -37.9% |
| Q1 2020 | $1,845,000 | -24.8% | 35,866 | -9.8% | 0.03% | +52.6% |
| Q4 2019 | $2,455,000 | +4.0% | 39,744 | +1.2% | 0.02% | +5.6% |
| Q3 2019 | $2,360,000 | -37.4% | 39,274 | -12.1% | 0.02% | -35.7% |
| Q2 2019 | $3,771,000 | -22.4% | 44,686 | -12.2% | 0.03% | -17.6% |
| Q1 2019 | $4,859,000 | +37.6% | 50,870 | +2.1% | 0.03% | +25.9% |
| Q4 2018 | $3,530,000 | +4.1% | 49,840 | +25.6% | 0.03% | +22.7% |
| Q3 2018 | $3,391,000 | -11.7% | 39,684 | +19.8% | 0.02% | -12.0% |
| Q2 2018 | $3,840,000 | +51.8% | 33,135 | +6.0% | 0.02% | +25.0% |
| Q1 2018 | $2,529,000 | +104.3% | 31,263 | +48.2% | 0.02% | +122.2% |
| Q4 2017 | $1,238,000 | +41.2% | 21,094 | +12.5% | 0.01% | +50.0% |
| Q3 2017 | $877,000 | +41.9% | 18,747 | +9.1% | 0.01% | +50.0% |
| Q2 2017 | $618,000 | +22.6% | 17,182 | +4.9% | 0.00% | +33.3% |
| Q1 2017 | $504,000 | -58.6% | 16,376 | -54.9% | 0.00% | -66.7% |
| Q4 2016 | $1,217,000 | +8.6% | 36,327 | -13.8% | 0.01% | 0.0% |
| Q3 2016 | $1,121,000 | +23.2% | 42,130 | +2.1% | 0.01% | +12.5% |
| Q2 2016 | $910,000 | -16.3% | 41,273 | +11.5% | 0.01% | -27.3% |
| Q1 2016 | $1,087,000 | -9.9% | 37,000 | +1.3% | 0.01% | -8.3% |
| Q4 2015 | $1,206,000 | -91.9% | 36,534 | -11.3% | 0.01% | -25.0% |
| Q3 2015 | $14,880,000 | +877.0% | 41,174 | +21.6% | 0.02% | +23.1% |
| Q2 2015 | $1,523,000 | +104.2% | 33,848 | +38.8% | 0.01% | +116.7% |
| Q1 2015 | $746,000 | +8.1% | 24,379 | +79.6% | 0.01% | +20.0% |
| Q4 2014 | $690,000 | +16.9% | 13,574 | -8.9% | 0.01% | 0.0% |
| Q3 2014 | $590,000 | – | 14,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |